Susquehanna International Group’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Susquehanna International Group’s Portfolio OYST Stock Details OYST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-108,443	Closed	-$1.21M	–	14239
2022 Q4	$1.21M	Buy	108,443 +86,256	+389%	+$836K	﹤0.01%	5771
2022 Q3	$125K	Sell	22,187 -35,167	-61%	-$220K	﹤0.01%	11483
2022 Q2	$248K	Buy	+57,354	New	+$326K	﹤0.01%	10090
2022 Q1	–	Sell	-28,021	Closed	-$512K	–	14400
2021 Q4	$512K	Buy	+28,021	New	+$356K	﹤0.01%	9141
2021 Q3	–	Sell	-10,448	Closed	-$180K	–	13889
2021 Q2	$180K	Buy	+10,448	New	+$199K	﹤0.01%	11702

Other funds holding OYST

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Susquehanna International Group's OYST Position: Q1 2023 in Review

Susquehanna International Group sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q1 2023, closing a stake of 108,443 shares — an estimated $1.21M sold.

Susquehanna International Group first reported a position in OYST in Q2 2021 and held it in 5 quarters. The position peaked at $1.21M in Q4 2022. 1 fund tracked by Wall St. Rank holds OYST as of Q1 2023.

Susquehanna International Group reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Susquehanna International Group sold 108,443 Oyster Point Pharma, Inc. Common Stock shares in Q1 2023, an estimated $1.21M.
Susquehanna International Group first reported a position in Oyster Point Pharma, Inc. Common Stock in Q2 2021 and held it in 5 quarters.
Susquehanna International Group's Oyster Point Pharma, Inc. Common Stock position peaked at $1.21M in Q4 2022.
1 fund tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q1 2023.

Based on Susquehanna International Group's 13F filing for Q1 2023, filed 16 May 2023.